HQL-79
货号：
10134-1mg 基本售价：
420.0 元 规格：
1 mg
产品信息
概述| 货号 | 10134-1mg |
| 描述 | HQL-79 is a selective inhibitor of hematopoietic prostaglandin D (PGD) synthase. Structurally, it is a synthetic tetrazole compound originally prepared as a possible antihistamine.1 Subsequent evaluation in models of allergy and asthma demonstrates the HQL-79 is orally available, and inhibits the synthesis of PGD2 (Item No. 12010).2 HQL-79 is thus a likely lead compound for the preparation of potent, selective hematopoietic PGD synthase inhibitors. |
性能| 供应商 | Cayman |
| 应用文献 |
1.Matsushita, K.,Nobutoshi, A. and Aritake, K. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. Japanese Journal of Pharmacology 78(1), 11-22 (1998).
2.Matsushita, K.,Nobutoshi, A. and Hizue, A. Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models. Japanese Journal of Pharmacology 78(1), 1-10 (1998).
|
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 377.5 |
| 分子式 | C22H27N5O |
| CAS号 | 162641-16-9 |
| 稳定性 | ≥ 1 year |
声明| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |
